Skip to main content
. 2014 Jul 24;2(6):953–959. doi: 10.3892/mco.2014.359

Table II.

Molecular analyses.

Markers Group Aa Group Bb
EGFR 25.8% (8/31) 29.1% (16/55)
TS 40% (4/10) 30% (7/21)
EML4-ALK 20% (2/10) 9.5% (2/21)
a

Pemetrexed-sensitive group (n=31).

b

Pemetrexed-resistant group (n=55);

EGFR, epithelial growth factor receptor; TS, thymidylate synthase; EML4-ALK, echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase. Data are presented as positive rate observed in the analysis (positive case number/total cases analyzed).